[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342487-105":59,"doc-detail-342487-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","the-urinary-microbiome-in-health-and-disease-relevance-for-bladder-cancer","The Urinary Microbiome in Health and Disease - Relevance for Bladder Cancer","","Bladder cancer (BC) is among the most frequently diagnosed cancers worldwide, and advances in DNA sequencing and high-throughput microbiota testing have revealed differences in urinary microbial profiles between healthy people and BC patients. The review synthesizes current evidence on urinary microbiome involvement, mechanisms, and how microbiota dysbiosis may affect BC pathogenesis, progression, and therapy response. It also examines urinary microbiota profiling for biomarker-based risk stratification, and for predicting responses to intravesical therapies and immunotherapy, while highlighting the need for further study of host–microbe interactions.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-urinary-microbiome-in-health-and-disease-relevance-for-bladder-cancer/342487/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-urinary-microbiome-in-health-and-disease-relevance-for-bladder-cancer/342487.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How could urinary microbiota be used in clinical practice for bladder cancer?","Question",{"text":112,"@type":113},"Urinary microbiota profiling may serve as a biomarker for risk stratification and for predicting patient response to intravesical therapies and immunotherapy, supporting more personalized treatment decisions.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},342487,1790211912,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Review  \nThe Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer  \nNatasa Kustrimovic 1, Giorgia Bilato 2, Lorenzo Mortara 2, *,† and Denisa Baci 2,3, *,†  \nCitation: Kustrimovic, N.; Bilato, G.; Mortara, L.; Baci, D. The Urinary Microbiome in Health and Disease:  \nRelevance for Bladder Cancer. Int. J. Mol. Sci. 2024, 25, 1732. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25031732](doi.org/10.3390/ijms25031732)  \nAcademic Editor: Giuseppe Lucarelli  \nReceived: 19 December 2023  \nRevised: 24 January 2024  \nAccepted: 28 January 2024  \nPublished: 31 January 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Universit del Piemonte Orientale, 28100 Novara, Italy; [natasa.kustrimovic@gmail.com](natasa.kustrimovic@gmail.com)  \n2 Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences,  \nUniversity of Insubria, 21100 Varese, Italy; gbilato@uninsubria.it  \n3 Molecular Cardiology Laboratory, IRCCS—Policlinico San Donato, 20097 Milan, Italy  \n* Correspondence: [lorenzo.mortara@uninsubria.it](lorenzo.mortara@uninsubria.it) (L.M.); [denisa.baci@grupposandonato.it](denisa.baci@grupposandonato.it) (D.B.)† These authors contributed equally to this work.  \nAbstract: Bladder cancer (BC) constitutes one of the most diagnosed types of cancer worldwide. Advancements in and new methodologies for DNA sequencing, leading to high-throughput microbiota testing, have pinpointed discrepancies in urinary microbial ﬁngerprints between healthy individuals and patients with BC. Although several studies suggest an involvement of microbiota dysbiosis in the pathogenesis, progression, and therapeutic response to bladder cancer, an established direct causal relationship remains to be elucidated due to the lack of standardized methodologies associated with such studies. This review compiles an overview of the microbiota of the human urinary tract in healthy and diseased individuals and discusses the evidence to date on microbiome involvement and potential mechanisms by which the microbiota may contribute to the development of BC. We also explore the potential proﬁling of urinary microbiota as a biomarker for risk stratiﬁcation, as well asthe prediction of the response to intravesical therapies and immunotherapy in BC patients. Further investigation into the urinary microbiome of BC patients is imperative to unravel the complexities of the role played by host–microbe interactions in shaping wellness or disease and yield valuable insights into and strategies for the prevention and personalized treatment of BC.  \nKeywords: bladder cancer; genitourinary microbiome; inﬂammation  \n1. Introduction  \nBladder cancer (BC) ranks as the 11th most frequently diagnosed typology of cancer globally, characterized by high incidence and mortality rates [1] . It is one of the most common tumors of the urological tract, second only to prostate cancer in Europe and the US [2] . Environmental factors, including smoking and occupational exposure, alongside genetic factors, contribute to BC development [3,4] .  \nBC is typically classiﬁed into muscle-invasive bladder cancer (MIBC), non-muscleinvasive bladder cancer (NMIBC), and metastatic tumor from distant sites. Around 70% of BC occurs in the cells of the bladder's innermost lining, i.e., the urothelium. NMIBC are less lethal and are easier to treat, usually by transurethral resection, even though the recurrence rates are quite high (40%–80%) [5] . In some instances, chemotherapy or radiotherapy can be included, as well as immunotherapy by Bacillus Clemette Guerin (BCG) vaccine, raising t","cbCaisycBXbz1QCe","https://ap.wps.com/l/cbCaisycBXbz1QCe","pdf",904704,23,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Bladder cancer overview and classification\n## Current treatment approaches and clinical challenges\n## Emerging systemic therapies and immune checkpoint inhibitors","[{\"question\":\"How could urinary microbiota be used in clinical practice for bladder cancer?\",\"answer\":\"Urinary microbiota profiling may serve as a biomarker for risk stratification and for predicting patient response to intravesical therapies and immunotherapy, supporting more personalized treatment decisions.\"}]","The Urinary Microbiome in Health and Disease - Relevance for Bladder Cancer | PDF",1790046798,58,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2ff52028bf0b5b2569b917c820249b7.webp",983,1390,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba50ffe6fa4585cede94ce7edc04e8d8.webp",982,1388,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f665660e7177208100549d2c789516b6.webp",981,1387,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f20245370423e0e8f63ad6801653527.webp",980,1385]